BACKGROUND: There is an increase in the sale of legal drugs in our country. One of these substances is kratom. Kratom (Mitragyna speciosa) is a partial agonist of the opioid kappa, mu, and delta receptors. It acts as a stimulant at low concentrations, making users feel more energetic and euphoric. It has sedative and antinociceptive effects at higher doses. CASE SUMMARY: An 18-year-old man collapsed during football training and required cardiopulmonary resuscitation; the initial rhythm was ventricular fibrillation managed by defibrillation. Laboratory parameters were unremarkable. Blood samples sent for toxicological evaluation were positive for kratom and caffeine. Echocardiographic examination, coronary computed tomography angiography, and cardiac magnetic resonance imaging did not prove the cause. Genetic testing did not find a pathogenic gene variant associated with familial ventricular fibrillation, but a variant of unknown significance was found in MYOM1. Given this situation, we implanted an implantable cardioverter-defibrillator (ICD) from the secondary prevention of sudden cardiac death (SCD) according to the guidelines of the European Society of Cardiology (ESC). No recurrence of ventricular arrhythmia has been reported by ambulatory ICD memory checks on our patient. DISCUSSION: In some country, kratom is freely available and sold as a plant, not a drug. Only incident cases of ventricular fibrillation after kratom use are described in the literature. There is insufficient scientific evidence linking kratom to ventricular fibrillation. This is an absolutely crucial case report of this type, which has not yet been published in similar circumstances in the world. Therefore, the development of ventricular fibrillation was assumed to be due to a combination of kratom, caffeine, and exercise. The safety profile and effects of kratom should be the subject of future research. We would like to stress the importance of reporting further case series for more scientific evidence and thus increasing the pressure for stricter availability and regulation of kratom in some countries, especially where it is over-the-counter.

Centre for Research on Internal and Cardiovascular Diseases Faculty of Medicine University of Ostrava Ostrava Czech Republic

Department of Internal Medicine and Cardiology University Hospital Ostrava Ostrava Czech Republic

Department of Medical Genetics University Hospital Ostrava Ostrava Czech Republic

Faculty of Medicine Institute of Forensic Medicine University of Ostrava Ostrava Czech Republic

Institute of Forensic Medicine University Hospital Ostrava Ostrava Czech Republic

Zobrazit více v PubMed

Eastlack SC, Cornett EM, Kaye AD. Kratom—pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther 2020;9:55–69. PubMed PMC

Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and kratom. Clin Toxicol 2008;46:146–152. PubMed

Lu J, Wei H, Wu J, Jamil MFA, Tan ML, Adenan MI, et al. . Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes. Pesce M, editor. PLoS One 2014;9:e115648. PubMed PMC

Kerrigan S, Basiliere S. Kratom: a systematic review of toxicological issues. Wiley Interdiscip Rev: Forensic Sci 2022;4:e1420. doi:10.1002/wfs2.1420. DOI

Burri H, Starck C, Auricchio A, Biffi M, Burri M, D’Avila A, et al. . EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). EP Europace 2021;23:983–1008. PubMed

Tuka V, Bělohlávek J. Sudden cardiac arrest/death during sports. Cor Vasa 2020;62:387–389.

Vostřelová Z, Vajdlová D, Vacek J, Mravčík V. Use and awareness of kratom among university students: questionnaire surveys. Adiktol Prevent Léčeb Praxi 2021;4:142–148.

ELJack A, Beasley M, Ibrahim H, Taha M, Werns S. Kratom-associated ventricular fibrillation. Am J Ther 2020;28:e792–e795. PubMed

Sheikh M, Ahmed N, Gandhi H, Chen O. Report of ventricular fibrillation in a 44-year-old man using kratom. BMJ Case Rep 2021;14:e237837. PubMed PMC

Leong Bin Abdullah MFI, Singh D. The adverse cardiovascular effects and cardiotoxicity of kratom (Mitragyna speciosa Korth.): a comprehensive review. Front Pharmacol 2021;12:726003. PubMed PMC